About 55% of office-based physicians responding to a government-sponsored survey said they use some form of electronic health-record system, and by and large, they're a satisfied lot, according to a report on the survey.
Read the full story: http://tinyurl.com/6vs6gph
Source: ModernHealthcare.com
The overwhelming majority (85%) of those who said they use an EHR also indicated that they were either very satisfied (38%) or somewhat satisfied (47%) with their systems. More than 7 in 10 said they were happy enough with their selection that they would purchase the same EHR system again. The Centers for Disease Control and Prevention's National Center for Health Statistics conducted the nationwide survey last year; findings were discussed in an HHS news release and on the CDC's website on Tuesday.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Researchers Identify Potential Biomarkers for SMA Motor Improvement Following Nusinersen Treatment
November 17th 2023A retrospective, exploratory analysis identifies biomarkers predictive of spinal muscular atrophy (SMA) response to nusinersen and suggests the efficacy of using machine learning algorithms to anticipate patient outcomes.
Read More